These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9123103)

  • 1. Distribution of lymphocyte subtypes in liver transplant recipients.
    Rayes N; Bechstein WO; Volk HP; Tullius SG; Nüssler N; Naumann U; Jonas S; Neuhaus R; Serke S; Neuhaus P
    Transplant Proc; 1997; 29(1-2):501-2. PubMed ID: 9123103
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution of lymphocyte subtypes in liver transplant recipients with viral reinfection or de novo malignancy.
    Rayes N; Bechstein WO; Tullius SG; Nüssler NC; Naumann U; Jonas S; Neuhaus R; Serke S; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):1846-7. PubMed ID: 9723303
    [No Abstract]   [Full Text] [Related]  

  • 3. CD28 regulation in liver transplant recipients treated with two different immunosuppressive regimens.
    Charco R; Caragol I; Urbán S; Lázaro JL; Murio E; Dávila R; Margarit C
    Transplant Proc; 1999 Dec; 31(8):3365-6. PubMed ID: 10616508
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenotypic changes in lymphocyte subpopulations in pediatric renal-transplant patients after T-cell depletion.
    Klaus G; Mostert K; Reckzeh B; Mueller TF
    Transplantation; 2003 Dec; 76(12):1719-24. PubMed ID: 14688522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.
    Klupp J; Glanemann M; Bechstein WO; Platz KP; Langrehr JM; Keck H; Settmacher U; Radtke C; Neuhaus R; Neuhaus P
    Transplant Proc; 1999; 31(1-2):1113-4. PubMed ID: 10083497
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic evaluation during the first year of life of infants born to cyclosporine-treated female kidney transplant recipients: analysis of lymphocyte subpopulations and immunoglobulin serum levels.
    Di Paolo S; Schena A; Morrone LF; Manfredi G; Stallone G; Derosa C; Procino A; Schena FP
    Transplantation; 2000 May; 69(10):2049-54. PubMed ID: 10852595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion from tacrolimus to Neoral in liver and kidney transplant recipients.
    Ott R; Bussenius-Kammerer M; Scholz D; Neuhaus R; Tolba RH; Fricke L; Müller V
    Transplant Proc; 2001; 33(7-8):3166-8. PubMed ID: 11750359
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunologic disorders in posttransplant lymphoma: therapeutic implications.
    Jacobs U; Niese D; Brensing KA; Eis-Hübinger A; Buszello H; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3249-50. PubMed ID: 8962259
    [No Abstract]   [Full Text] [Related]  

  • 9. Neurologic symptoms improve in patients with Wilson's disease despite immunosuppression.
    Schumacher G; Mueller AR; Platz KP; Neuhaus R; Bechstein WO; Becker M; Luck W; Neuhaus P
    Transplant Proc; 1996 Dec; 28(6):3099-100. PubMed ID: 8962200
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunity in maintenance immunosuppression with and without cyclosporine in long-term kidney transplant recipients.
    Yamashita M; Aikawa A
    Transplant Proc; 2000 Nov; 32(7):1768-72. PubMed ID: 11119927
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic rejection in pediatric liver transplantation.
    Cho JH; Bhatnagar V; Andreani P; Muiesan P; Portmann B; Baker A; Mieli-Vergani G; Gibbs P; Rela M; Heaton ND
    Transplant Proc; 1997; 29(1-2):452-3. PubMed ID: 9123078
    [No Abstract]   [Full Text] [Related]  

  • 12. Post-transplant monitoring of NK cell counts as a simple approach to predict the occurrence of opportunistic infection in liver transplant recipients.
    Fernández-Ruiz M; Silva JT; López-Medrano F; Allende LM; San Juan R; Cambra F; Justo I; Paz-Artal E; Jiménez C; Aguado JM
    Transpl Infect Dis; 2016 Aug; 18(4):552-65. PubMed ID: 27260953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of immunosuppressive agents after living related donor liver transplantation.
    Tanaka M; Otobe Y; Hashimoto T; Shimizu Y; Suzuki T; Nakamura Y; Itoh K; Satoh M; Ueda N; Manabe T
    Transplant Proc; 1996 Aug; 28(4):2402-3. PubMed ID: 8769268
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation.
    Aguilar P; Mathieu CP; Clerc G; Ethevenot G; Fajraoui M; Mattei S; Faure GC; Bene MC
    J Heart Lung Transplant; 2006 Feb; 25(2):200-5. PubMed ID: 16446221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine levels among transplant recipients: effect of immunosuppressive protocols.
    Mor E; Helfmann L; Lustig S; Bar-Nathan N; Yussim A; Sela BA
    Transplant Proc; 2001 Sep; 33(6):2945-6. PubMed ID: 11543802
    [No Abstract]   [Full Text] [Related]  

  • 16. Individualized Immunosuppressive Protocol of Liver Transplant Recipient Should be Made Based on Splenic Function Status.
    Song JY; Du GS; Xiao L; Chen W; Suo LL; Gao Y; Feng LK; Shi BY
    Chin Med J (Engl); 2016 Jun; 129(11):1340-6. PubMed ID: 27231173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-centre experience with cyclosporine microemulsion versus tacrolimus in 100 randomized liver transplant recipients: midterm efficacy and safety.
    Loinaz C; Marin LM; González-Pinto I; Gómez R; Jiménez C; Moreno E
    Transplant Proc; 2001; 33(7-8):3439-41. PubMed ID: 11750472
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
    Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
    Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506.
    Whiteside TL; Wilson J; Bryant J; Zeevi A; Abu el-Magd K; Jain A; Alessiani M; Fung J; Herberman RB; Starzl TE
    Transplant Proc; 1991 Dec; 23(6):3047-51. PubMed ID: 1721356
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with the use of basiliximab in liver transplantation--use in pediatric and adult recipients in combination with cyclosporine or tacrolimus.
    Petz W; Spada M; Bertani A; Lucianctti A; Casagrande F; Guizzetti M; Corno V; Colledan M; Strazzabosco M; Gridelli B
    Transplant Proc; 2002 Aug; 34(5):1966-7. PubMed ID: 12176648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.